Thrombosis with thrombocytopenia syndrome (TTS), which develops after administration of an adenovirus vector-based vaccine, is mediated by platelet-activating antibodies to platelet factor 4 (PF4). This evidence concerns the gene PF4 and deep vein thrombosis.